Researchers Use Nanoparticles to Test Treatment for Liver Disease

June 25, 2018 | Katie Neith

In an effort to improve options for those with liver cancer, a group of researchers have identified a way of potentially treating a broad range of liver diseases and perhaps even other types of cancer.

Continue Reading

Saswati Chatterjee, Ph.D., Seeks Cure for Hemophilia

February 21, 2018 | Katie Neith

Saswati Chatterjee, Ph.D., a professor in the Department of Surgery and member of Beckman Research Institute of City of Hope, thinks she may know a way to cure hemophilia A.

New Hire: Daniel Jae Kim

January 25, 2018 | City of Hope

Daniel Jae Kim, M.D., is based at City of Hope's South Pasadena facility and specializes in hematology and oncology.

Larry Kwak, M.D., Ph.D., Receives Grant for Promising Lymphoma Work

January 12, 2018 | Letisia Marquez

Larry Kwak, M.D., Ph.D., received a grant to support his work with mantle cell lymphoma from the Leukemia & Lymphoma Society, the world’s largest voluntary health organization dedicated to fighting blood cancer.

Multiple Myeloma CAR T Cell Trial to launch in 2017

April 3, 2017 | Travis Marshall

An upcoming phase 1 clinical trial at City of Hope will look at the effects of CAR T cells programmed to target a protein called CS-1, which is found on myeloma cells.

Researchers tackle two difficult-to-treat lymphomas

February 2, 2017 | Letisia Marquez

New study in the Journal of Clinical Oncology concludes that patients with relapsed or treatment-resistant double-hit and/or double-expressor lymphomas didn’t respond as well to the transplantation as diffuse large B-cell lymphoma patients who did not have those types of lymphoma.

Hodgkin Lymphoma Trial Results Promising

January 9, 2017 | Abe Rosenberg

Everything changed when a Hodgkin lymphoma patient joined a Phase II clinical trial examining the effectiveness of brentuximab vedotin (BV) after a failed transplant. The BV worked immediately, achieving a complete remission which, year after year, proved to be durable beyond anyone's expectations.

Steven T. Rosen, M.D. on the Latest Breakthroughs in Blood Cancer Treatment

December 16, 2016 | City of Hope

The long-term strategies offered by City of Hope’s Hematologic Malignancies (HM) Program have dramatically improved the lives of patients with leukemia, lymphoma, Hodgkin’s disease and multiple myeloma.

ASH 2016: Innovative new trials show promise for lymphoma and multiple myeloma patients

December 7, 2016 | City of Hope

Numerous clinical trials, which lay the groundwork for novel approaches to lymphoma and multiple myeloma therapies, could ultimately lead to new treatments that improve survival and quality of life for patients with those and other diseases. Additional studies give new insight into best practices for the treatment of various blood cancers.

Treatment for acute lymphoblastic leukemia patients has improved, but challenges persist

September 14, 2016 | Leti Marquez

Children with acute lymphoblastic leukemia (ALL) are going into remission at higher rates than ever before - thanks to better treatment that stems from leading-edge clinical trials - but adults with ALL still face significant hurdles in overcoming the disease.